codeage glp 1 probiotic reviews Explore GLP-1 Probiotic+, featuring a blend of probiotics including Akkermansia, Clostridium, and Bifidobacterium, complemented by chicory inulin., #codeage #probiotics #supplements including Clostridium butyricum Codeage Glp-1 Probiotic+ Balance, Live

This guide focuses on practical food choices and timing that many people find supportive as fullness cues stabilize

In comparison to sitagliptin, semaglutide has been shown to significantly reduce the 12-month risk of cognitive deficits, dementia, and epilepsy.[63] In PCOS, a meta-analysis indicated that exenatide and liraglutide exhibit stronger effects on insulin sensitivity and BMI reduction than metformin.[71] A 24-week study found that exenatide led to a significantly higher rate of spontaneous pregnancies and more regular menstrual cycles compared to metformin.[72] Although rapid weight loss in some contexts is associated with an increased risk of frailty fractures, GLP-1RAs may mitigate this effect.[73, 74] Both exenatide and dulaglutide were found to increase bone mineral density, while lixisenatide and liraglutide were associated with a reduced risk of fractures, suggesting differential effects of GLP-1RAs on bone metabolism.[74] OTHER CONSIDERATIONS Side effects and adverse events related to GLP1-RAs While GLP-1RAs are credited with a growing list of health benefits, they have also been associated with a wide variety of adverse effects that may vary among agents.[6, 21] Common side effects include nausea, vomiting, diarrhea, mild tachycardia, and injection site reactions.[75] A pooled analysis of 33 clinical trials (n=13,548) found an increased risk of treatment discontinuation due to gastrointestinal effects such as nausea and vomiting.[6] Potential adverse events include pancreatitis, cholelithiasis, and dehydration.[76] Rodent studies and one observational study in humans have raised concerns about GLP-1RAs impact on thyroid cancer risk

Thats not how GLP-1s work

All GLP analogs were subcutaneous injectables until the arrival of Rybelsus (oral semaglutide) in 2020

But a growing body of research, and a wave of real-world experience, suggests these drugs may have meaningful benefits for people with T1D too: lower daily insulin doses, flatter glucose curves on your CGM, and potentially better long-term protection for your heart and kidneys

Given the limited published data on GLP-1 use in GDM, this platform provided the most relevant and up-to-date information, including ongoing studies with detailed protocols not yet available in peer-reviewed literature